Gilead Sciences, Inc. and Walgreens Boots Alliance, Inc.: A Detailed Gross Profit Analysis

Gilead vs. Walgreens: A Decade of Gross Profit Trends

__timestampGilead Sciences, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 20142110200000021569000000
Thursday, January 1, 20152863300000026753000000
Friday, January 1, 20162612900000029874000000
Sunday, January 1, 20172173600000029162000000
Monday, January 1, 20181727400000030792000000
Tuesday, January 1, 20191777400000028159000000
Wednesday, January 1, 20202011700000026077000000
Friday, January 1, 20212070400000028067000000
Saturday, January 1, 20222162400000028266000000
Sunday, January 1, 20232061800000027072000000
Monday, January 1, 20247820000026524000000
Loading chart...

Unleashing insights

A Comparative Analysis of Gross Profit Trends: Gilead Sciences vs. Walgreens Boots Alliance

In the ever-evolving landscape of the pharmaceutical and retail sectors, Gilead Sciences, Inc. and Walgreens Boots Alliance, Inc. stand as titans. From 2014 to 2023, these companies have showcased intriguing trends in their gross profits. Gilead Sciences experienced a peak in 2015, with a gross profit increase of approximately 36% from the previous year, before witnessing a gradual decline. By 2023, their gross profit had decreased by about 28% from its 2015 high. In contrast, Walgreens Boots Alliance demonstrated a more stable trajectory, peaking in 2018 with a 43% increase from 2014. Despite a slight dip in 2023, their gross profit remained robust, only 14% below their peak. This analysis highlights the dynamic nature of these industries and the resilience of these companies in navigating economic challenges.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025